Skip to main content
Top
Published in: Annals of Hematology 7/2013

01-07-2013 | Original Article

Low expression of glucocorticoid receptor alpha isoform in adult immune thrombocytopenia correlates with glucocorticoid resistance

Authors: Liangliang Ma, Meiyun Fang, Yan Liang, Yang Xiang, Zhilin Jia, Xiuli Sun, Yi Wang, Jixia Qin

Published in: Annals of Hematology | Issue 7/2013

Login to get access

Abstract

The expression of glucocorticoid receptor (GR) isoforms has been linked to glucocorticoid (GC) resistance in various diseases treated with GC. However, existing data are conflicting in these diseases, and little information is available regarding immune thrombocytopenia (ITP). To further investigate the role of GR isoforms in GC resistance in adult ITP patients, we measured the mRNA expression of GR isoforms (GRα, GRβ, GRγ, GRp) in peripheral blood mononuclear cells (PBMC) from 54 newly diagnosed ITP patients, including GC-sensitive (GCS) and GC-resistant (GCR) patients and 35 healthy volunteers. The GRα and GRβ proteins in PBMC, nuclear factor-κB (NF-κB), and activator protein-1 (AP-1) in the nucleus were detected by Western blotting. Compared to normal subjects, both GRα and GRβ mRNAs were significantly increased in ITP patients (p < 0.05), while there was no significant difference in the mRNA expression of GRγ and GRp. Compared to GCR patients, the expressions of GRα mRNA and GRα protein were significantly higher in GCS patients (p < 0.05). Moreover, no significant difference in the mRNA expression of the GRβ, GRγ, and GRp isoforms was observed between GCS and GCR patients and the GRβ protein could not be detected. Compared to GCS group, the expression of p65/NF-κB was significantly higher in the GCR group (p < 0.05). Overall, we did not find differences in c-Jun/AP-1 protein expression between GCS and GCR patients. In summary, GC resistance in adult ITP patients is associated with a reduced expression of GRα, which may be related with increased NF-κB. GRβ was very low and may not be involved in GC resistance in adult ITP, warranting further exploration.
Literature
1.
go back to reference Reichardt HM, Schütz G (1998) Glucocorticoid signaling-multiple variations of a common theme. Mol Cell Endocrinol 146:1–6PubMedCrossRef Reichardt HM, Schütz G (1998) Glucocorticoid signaling-multiple variations of a common theme. Mol Cell Endocrinol 146:1–6PubMedCrossRef
2.
go back to reference Schaaf MJM, Cidlowski JA (2002) Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 83:37–48PubMedCrossRef Schaaf MJM, Cidlowski JA (2002) Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 83:37–48PubMedCrossRef
3.
go back to reference Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R (2004) Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 11:S45–S55PubMedCrossRef Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R (2004) Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 11:S45–S55PubMedCrossRef
4.
go back to reference Seki M, Ushiyama C, Seta N, Abe K, Fukazawa T, Asakawa J et al (1998) Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus. Arthritis Rheum 41:823–830PubMedCrossRef Seki M, Ushiyama C, Seta N, Abe K, Fukazawa T, Asakawa J et al (1998) Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus. Arthritis Rheum 41:823–830PubMedCrossRef
5.
go back to reference Kofler R, Schmidt S, Kofler A, Ausserlechner MJ (2003) Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia. J Endocrinol 178:19–27PubMedCrossRef Kofler R, Schmidt S, Kofler A, Ausserlechner MJ (2003) Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia. J Endocrinol 178:19–27PubMedCrossRef
6.
go back to reference Oakley RH, Sar M, Cidlowski JA (1996) The human glucocorticoid receptor beta isoform expression, biochemical properties, and putative function. J Biol Chem 271:9550–9559PubMedCrossRef Oakley RH, Sar M, Cidlowski JA (1996) The human glucocorticoid receptor beta isoform expression, biochemical properties, and putative function. J Biol Chem 271:9550–9559PubMedCrossRef
7.
go back to reference Hecht K, Carlstedt-Duke J, Stierna P, Gustafsson J, Brönnegârd M, Wikström AC (1997) Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J Biol Chem 272:26659–26664PubMedCrossRef Hecht K, Carlstedt-Duke J, Stierna P, Gustafsson J, Brönnegârd M, Wikström AC (1997) Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J Biol Chem 272:26659–26664PubMedCrossRef
8.
go back to reference Bamberger CM, Bamberger AM, de Castro M, Chrousos GP (1995) Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95:2435–2441PubMedCrossRef Bamberger CM, Bamberger AM, de Castro M, Chrousos GP (1995) Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95:2435–2441PubMedCrossRef
9.
go back to reference Piotrowski P, Burzyñski M, Lianeri M, Mostowska M, Wudarski M, Chwalinska-Sadowska H et al (2007) Glucocorticoid receptor beta splice variant expression in patients with high and low activity of systemic lupus erythematosus. Folia Histochem Cytobiol 45:339–342PubMed Piotrowski P, Burzyñski M, Lianeri M, Mostowska M, Wudarski M, Chwalinska-Sadowska H et al (2007) Glucocorticoid receptor beta splice variant expression in patients with high and low activity of systemic lupus erythematosus. Folia Histochem Cytobiol 45:339–342PubMed
10.
go back to reference Goecke A, Guerrero J (2006) Glucocorticoid receptor beta in acute and chronic inflammatory conditions: clinical implications. Immunobiology 211:85–96PubMedCrossRef Goecke A, Guerrero J (2006) Glucocorticoid receptor beta in acute and chronic inflammatory conditions: clinical implications. Immunobiology 211:85–96PubMedCrossRef
11.
go back to reference Inui S, Sumikawa Y, Asada H, Itami S (2010) Glucocorticoid resistance in atopic dermatitis associated with decreased expression of glucocorticoid receptor-a in peripheral blood mononuclear cells. J Dermatol 37:496–499PubMedCrossRef Inui S, Sumikawa Y, Asada H, Itami S (2010) Glucocorticoid resistance in atopic dermatitis associated with decreased expression of glucocorticoid receptor-a in peripheral blood mononuclear cells. J Dermatol 37:496–499PubMedCrossRef
12.
go back to reference Koga Y, Matsuzaki A, Suminoe A, Hattori H, Kanemitsu S, Hara T (2005) Differential mRNA expression of glucocorticoid receptor α and β is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children. Pediatr Blood Cancer 45:121–127PubMedCrossRef Koga Y, Matsuzaki A, Suminoe A, Hattori H, Kanemitsu S, Hara T (2005) Differential mRNA expression of glucocorticoid receptor α and β is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children. Pediatr Blood Cancer 45:121–127PubMedCrossRef
13.
go back to reference Beger C, Gerdes K, Lauten M, Tissing WJ, Fernandez-Munoz I, Schrappe M et al (2003) Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach. Br J Haematol 122:245–252PubMedCrossRef Beger C, Gerdes K, Lauten M, Tissing WJ, Fernandez-Munoz I, Schrappe M et al (2003) Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach. Br J Haematol 122:245–252PubMedCrossRef
14.
go back to reference Sánchez-Vega B, Krett N, Rosen ST, Gandhi V (2006) Glucocorticoid receptor transcriptional isoforms and resistance in multiple myeloma cells. Mol Cancer Ther 5:3062–3370PubMedCrossRef Sánchez-Vega B, Krett N, Rosen ST, Gandhi V (2006) Glucocorticoid receptor transcriptional isoforms and resistance in multiple myeloma cells. Mol Cancer Ther 5:3062–3370PubMedCrossRef
15.
go back to reference Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenia of adults and children: report from an international working group. Blood 113:2386–2393PubMedCrossRef Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenia of adults and children: report from an international working group. Blood 113:2386–2393PubMedCrossRef
16.
go back to reference Goleva E, Li LB, Eves PT, Strand MJ, Martin RJ, Leung DY (2006) Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 173:607–616PubMedCrossRef Goleva E, Li LB, Eves PT, Strand MJ, Martin RJ, Leung DY (2006) Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 173:607–616PubMedCrossRef
17.
go back to reference Hamid QA, Wenzel SE, Hauk PJ, Tsicopoulos A, Wallaert B, Lafitte JJ et al (1999) Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 159:1600–1604PubMedCrossRef Hamid QA, Wenzel SE, Hauk PJ, Tsicopoulos A, Wallaert B, Lafitte JJ et al (1999) Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 159:1600–1604PubMedCrossRef
18.
go back to reference Honda M, Orii F, Ayabe T, Imai S, Ashida T, Obara T et al (2000) Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 118:859–866PubMedCrossRef Honda M, Orii F, Ayabe T, Imai S, Ashida T, Obara T et al (2000) Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 118:859–866PubMedCrossRef
19.
go back to reference Towers R, Naftali T, Gabay G, Carlebach M, Klein A, Novis B (2005) High levels of glucocorticoid receptors in patients with active Crohn’s disease may predict steroid resistance. Br Soc Immunol Clin Exp Immunol 141:357–362CrossRef Towers R, Naftali T, Gabay G, Carlebach M, Klein A, Novis B (2005) High levels of glucocorticoid receptors in patients with active Crohn’s disease may predict steroid resistance. Br Soc Immunol Clin Exp Immunol 141:357–362CrossRef
20.
go back to reference Boylea B, Butza H, Likob I, Zalatnai A, Toth M, Feldman K et al (2010) Expression of glucocorticoid receptor isoforms in human adrenocortical adenomas. Steroids 75:695–700CrossRef Boylea B, Butza H, Likob I, Zalatnai A, Toth M, Feldman K et al (2010) Expression of glucocorticoid receptor isoforms in human adrenocortical adenomas. Steroids 75:695–700CrossRef
21.
go back to reference Harrman EG, Kaspers GJ, Pieters R, Rottier MM, Veerman AJ (2004) Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticoid resistance in childhood leukemia. Leukemia 18:530–537CrossRef Harrman EG, Kaspers GJ, Pieters R, Rottier MM, Veerman AJ (2004) Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticoid resistance in childhood leukemia. Leukemia 18:530–537CrossRef
22.
go back to reference Choi BR, Kwon JH, Gong SJ, Kwon MS, Cho JH, Kim JH et al (2006) Expression of glucocorticoid receptor mRNAs in glucocorticoid-resistant nasal polyps. Exp Mol Med 38:466–473PubMedCrossRef Choi BR, Kwon JH, Gong SJ, Kwon MS, Cho JH, Kim JH et al (2006) Expression of glucocorticoid receptor mRNAs in glucocorticoid-resistant nasal polyps. Exp Mol Med 38:466–473PubMedCrossRef
23.
go back to reference Jakieła B, Bochenek G, Sanak M (2010) Glucocorticoid receptor isoforms in steroid dependent asthma. Pol Arch Med Wewn 120:214–221PubMed Jakieła B, Bochenek G, Sanak M (2010) Glucocorticoid receptor isoforms in steroid dependent asthma. Pol Arch Med Wewn 120:214–221PubMed
24.
go back to reference Lauten M, Carion G, Asgedom G, Welte K, Schrappe M (2003) Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia. Haematologica 88:1253–1258PubMed Lauten M, Carion G, Asgedom G, Welte K, Schrappe M (2003) Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia. Haematologica 88:1253–1258PubMed
25.
go back to reference Rivers C, Levy A, Hancock J, Lightman S, Norman M (1999) Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. J Clin Endocrinol Metab 84:4283–4286PubMedCrossRef Rivers C, Levy A, Hancock J, Lightman S, Norman M (1999) Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. J Clin Endocrinol Metab 84:4283–4286PubMedCrossRef
26.
go back to reference Tissing WJ, Lauten M, Meijerink JP, den Boer ML, Koper JW, Sonneveld P et al (2005) Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia. Haematologica 90:1279–1281PubMed Tissing WJ, Lauten M, Meijerink JP, den Boer ML, Koper JW, Sonneveld P et al (2005) Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia. Haematologica 90:1279–1281PubMed
27.
go back to reference Eggert M, Klüter A, Rusch D, Schmidt KL, Dotzlaw H, Schulz M et al (2002) Expression analysis of the glucocorticoid receptor and the nuclear factor-kB subunit p50 in lymphocytes from patients with rheumatoid arthritis. J Rheumatol 29:2500–2506PubMed Eggert M, Klüter A, Rusch D, Schmidt KL, Dotzlaw H, Schulz M et al (2002) Expression analysis of the glucocorticoid receptor and the nuclear factor-kB subunit p50 in lymphocytes from patients with rheumatoid arthritis. J Rheumatol 29:2500–2506PubMed
28.
go back to reference Neeck G, Kluter A, Dotzlaw H, Eggert M (2002) Involvement of the glucocorticoid receptor in the pathogenesis of rheumatoid arthritis. Ann NY Acad Sci 966:491–495PubMedCrossRef Neeck G, Kluter A, Dotzlaw H, Eggert M (2002) Involvement of the glucocorticoid receptor in the pathogenesis of rheumatoid arthritis. Ann NY Acad Sci 966:491–495PubMedCrossRef
29.
go back to reference Matsuda A, Tanaka A, Muto S, Ohmori K, Furusaka T, Jung K et al (2010) A novel NF-KB inhibitor improves glucocorticoid sensitivity of canine neoplastic lymphoid cells by up-regulating expression of glucocorticoid receptors. Res Vet Sci 89:378–382PubMedCrossRef Matsuda A, Tanaka A, Muto S, Ohmori K, Furusaka T, Jung K et al (2010) A novel NF-KB inhibitor improves glucocorticoid sensitivity of canine neoplastic lymphoid cells by up-regulating expression of glucocorticoid receptors. Res Vet Sci 89:378–382PubMedCrossRef
30.
go back to reference Bailey S, Hall AG, Pearson AD, Redfern CP (2001) The role of AP-1 in glucocorticoid resistance in leukaemia. Leukemia 15:391–397PubMedCrossRef Bailey S, Hall AG, Pearson AD, Redfern CP (2001) The role of AP-1 in glucocorticoid resistance in leukaemia. Leukemia 15:391–397PubMedCrossRef
Metadata
Title
Low expression of glucocorticoid receptor alpha isoform in adult immune thrombocytopenia correlates with glucocorticoid resistance
Authors
Liangliang Ma
Meiyun Fang
Yan Liang
Yang Xiang
Zhilin Jia
Xiuli Sun
Yi Wang
Jixia Qin
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 7/2013
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-1705-5

Other articles of this Issue 7/2013

Annals of Hematology 7/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine